Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $866.9 million.

  • Fresenius Medical Care AG's Cash from Operations fell 1985.89% to $866.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 1358.37%. This contributed to the annual value of $2.5 billion for FY2024, which is 986.26% down from last year.
  • Fresenius Medical Care AG's Cash from Operations amounted to $866.9 million in Q3 2025, which was down 1985.89% from $877.3 million recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Cash from Operations peaked at $1.1 billion during Q2 2021, and registered a low of $138.0 million during Q1 2024.
  • Its 5-year average for Cash from Operations is $660.4 million, with a median of $773.6 million in 2023.
  • In the last 5 years, Fresenius Medical Care AG's Cash from Operations tumbled by 6115.35% in 2021 and then skyrocketed by 8430.62% in 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Cash from Operations (Quarter) stood at $765.3 million in 2021, then fell by 20.01% to $612.1 million in 2022, then rose by 26.37% to $773.6 million in 2023, then rose by 14.93% to $889.1 million in 2024, then decreased by 2.49% to $866.9 million in 2025.
  • Its last three reported values are $866.9 million in Q3 2025, $877.3 million for Q2 2025, and $171.5 million during Q1 2025.